Cargando…

Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases

It is critical to identify biomarkers for neurological diseases (NLDs) to accelerate drug discovery for effective treatment of patients of diseases that currently lack such treatments. In this work, we retrieved genotyping and clinical data from 1,223 UK Biobank participants to identify genetic and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Simon, Arif, Muhammad, Song, Xiya, Uhlén, Mathias, Mardinoglu, Adil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194858/ https://www.ncbi.nlm.nih.gov/pubmed/35711735 http://dx.doi.org/10.3389/fnmol.2022.889728

Ejemplares similares

Multi-omics approaches for revealing the complexity of cardiovascular disease
por: Doran, Stephen, et al.
Publicado: (2021)

Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer’s and Parkinson’s Diseases
por: Lam, Simon, et al.
Publicado: (2021)

Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis
por: Bayraktar, Abdulahad, et al.
Publicado: (2021)

Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
por: Rosario, Dorines, et al.
Publicado: (2020)

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
por: Larsson, Ida, et al.
Publicado: (2020)

ESS: A Tool for Genome-Scale Quantification of Essentiality Score for Reaction/Genes in Constraint-Based Modeling
por: Zhang, Cheng, et al.
Publicado: (2018)

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease
por: Yang, Hong, et al.
Publicado: (2021)

Revealing the Metabolic Alterations during Biofilm Development of Burkholderia cenocepacia Based on Genome-Scale Metabolic Modeling
por: Altay, Ozlem, et al.
Publicado: (2021)

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
por: Zhong, Wen, et al.
Publicado: (2021)

The application of weighted gene co-expression network analysis and support vector machine learning in the screening of Parkinson’s disease biomarkers and construction of diagnostic models
por: Cai, Lijun, et al.
Publicado: (2023)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
por: Bellomo, Giovanni, et al.
Publicado: (2021)

New Challenges to Study Heterogeneity in Cancer Redox Metabolism
por: Benfeitas, Rui, et al.
Publicado: (2017)

Metabolic Network-Based Identification and Prioritization of Anticancer Targets Based on Expression Data in Hepatocellular Carcinoma
por: Bidkhori, Gholamreza, et al.
Publicado: (2018)

Systems biology perspective for studying the gut microbiota in human physiology and liver diseases
por: Altay, Ozlem, et al.
Publicado: (2019)

Machine learning based on metabolomics reveals potential targets and biomarkers for primary Sjogren’s syndrome
por: Wang, Kai, et al.
Publicado: (2022)

Editorial: Mitochondrial therapy in neurological diseases
por: Chang, Jui-Chih, et al.
Publicado: (2022)

Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020)

Mitochondrial protein dysfunction in pathogenesis of neurological diseases
por: Wang, Liang, et al.
Publicado: (2022)

Addressing the heterogeneity in liver diseases using biological networks
por: Lam, Simon, et al.
Publicado: (2020)

Editorial: Ion Channels: Therapeutic Targets for Neurological Disease
por: Hou, Panpan, et al.
Publicado: (2021)

Choroid plexus epithelium and its role in neurological diseases
por: Liu, Ruizhen, et al.
Publicado: (2022)

Neuron-astrocyte omnidirectional signaling in neurological health and disease
por: Pathak, Dhruba, et al.
Publicado: (2023)

Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma
por: Lundgren, Sebastian, et al.
Publicado: (2019)

Editorial: Application of Systems Biology in Molecular Characterization and Diagnosis of Cancer
por: Zhang, Cheng, et al.
Publicado: (2021)

Editorial: Application of systems biology in molecular characterization and diagnosis of cancer, Volume II
por: Wei, Yongjun, et al.
Publicado: (2022)

Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases
por: Soares, Milena B. P., et al.
Publicado: (2022)

m6A methylation: Critical roles in aging and neurological diseases
por: Fan, Yishu, et al.
Publicado: (2023)

Editorial: Molecular advances and applications of machine learning in understanding autism and comorbid psychiatric disorders
por: Salloum-Asfar, Salam
Publicado: (2023)

Insights on therapeutic potential of clemastine in neurological disorders
por: Jiang, Sufang, et al.
Publicado: (2023)

Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders
por: Proffitt, Ceri, et al.
Publicado: (2022)

Mitochondrial Protein PGAM5 Emerges as a New Regulator in Neurological Diseases
por: Liang, Min-Zong, et al.
Publicado: (2021)

A Machine Learning Approach in Autism Spectrum Disorders: From Sensory Processing to Behavior Problems
por: Alateyat, Heba, et al.
Publicado: (2022)

Editorial: Leveraging machine learning for omics-driven biomarker discovery
por: Li, Sheng, et al.
Publicado: (2023)

Glymphatic system: an emerging therapeutic approach for neurological disorders
por: Gao, Ying, et al.
Publicado: (2023)

Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
por: Karnevi, Emelie, et al.
Publicado: (2017)

Urine-derived stem cells in neurological diseases: current state-of-the-art and future directions
por: Cavaleiro, Carla, et al.
Publicado: (2023)

Machine learning-based predictive models and drug prediction for schizophrenia in multiple programmed cell death patterns
por: Feng, Yu, et al.
Publicado: (2023)

Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling
por: Agren, Rasmus, et al.
Publicado: (2014)

The role of Gadd45b in neurologic and neuropsychiatric disorders: An overview
por: Shen, Xiao-yue, et al.
Publicado: (2022)

Zebrafish Is a Powerful Tool for Precision Medicine Approaches to Neurological Disorders
por: Ochenkowska, Katarzyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_plran53sh8e8req5aa51svag0d